Expert Opinion on Pharmacotherapy, Volume 15, Issue 3 (2014)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Pharmacotherapy, Volume 15, Issue 3 (2014)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Volume 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Editorial

Editorial
Sumatriptan in clinical practice: effectiveness in migraine and the problem of psychiatric comorbidity
Flavia Napoletano, Luana Lionetto & Paolo Martelletti
Pages: 303-305
Published online: 09 Nov 2013
AbstractforSumatriptan in clinical practice: effectiveness in migraine and the problem of psychiatric comorbidity | Full Text | References | PDF (135.2 KB)
  • 2381 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Optimal phosphate control: still an unmet need in chronic kidney disease patients
Francesco Locatelli MD & Lucia Del Vecchio MD
Pages: 307-309
Published online: 27 Nov 2013
AbstractforOptimal phosphate control: still an unmet need in chronic kidney disease patients | Full Text | References | PDF (133.4 KB)
  • 1019 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Original Research

Article
The glycemic/metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus
Yuri Ono, Akinobu Nakamura, Kyu Yong Cho & Hiroshi Nomoto
Pages: 311-324
Published online: 13 Dec 2013
AbstractforThe glycemic/metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus | Full Text | References | PDF (957.6 KB)
  • 153 Views
  • 6 CrossRef citations
  • 0Altmetric

Reviews

Review Article
The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease
Adetola A Kassim MD MS & Michael R DeBaun MD MPH
Pages: 325-336
Published online: 07 Jan 2014
AbstractforThe case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease | Full Text | References | PDF (246.1 KB)
  • 647 Views
  • 20 CrossRef citations
  • 0Altmetric
Review Article
Protein kinase inhibitors in renal cell carcinoma
Amaury Daste, Thomas Grellety, Marine Gross-Goupil & Alain Ravaud
Pages: 337-351
Published online: 16 Dec 2013
AbstractforProtein kinase inhibitors in renal cell carcinoma | Full Text | References | PDF (364.1 KB)
  • 281 Views
  • 8 CrossRef citations
  • 0Altmetric
Review Article
Leukotriene receptor antagonists pranlukast and montelukast for treating asthma
Hiroto Matsuse MD PhD & Shigeru Kohno MD PhD
Pages: 353-363
Published online: 19 Dec 2013
AbstractforLeukotriene receptor antagonists pranlukast and montelukast for treating asthma | Full Text | References | PDF (423.2 KB)
  • 1043 Views
  • 30 CrossRef citations
  • 0Altmetric
Review Article
Obeticholic acid and budesonide for the treatment of primary biliary cirrhosis
Marina G Silveira MD & Keith D Lindor MD
Pages: 365-372
Published online: 02 Jan 2014
AbstractforObeticholic acid and budesonide for the treatment of primary biliary cirrhosis | Full Text | References | PDF (226.9 KB)
  • 888 Views
  • 30 CrossRef citations
  • 0Altmetric
Review Article
Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials
Naren P Rao MBBS MD & Gary Remington MD PhD FRCPC
Pages: 373-383
Published online: 20 Dec 2013
AbstractforTargeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials | Full Text | References | PDF (510.2 KB)
  • 433 Views
  • 6 CrossRef citations
  • 0Altmetric
Review Article
Fesoterodine fumarate and the oxybutynin ring for the treatment of urinary incontinence in women
Angie Rantell, Linda Cardozo & Sushma Srikrishna
Pages: 385-393
Published online: 27 Dec 2013
AbstractforFesoterodine fumarate and the oxybutynin ring for the treatment of urinary incontinence in women | Full Text | References | PDF (297.8 KB)
  • 193 Views
  • 0 CrossRef citations
  • 0Altmetric

Drug Evaluations

Raltegravir as antiretroviral therapy in HIV/AIDS
Malika Sharma MD FRCPC & Sharon L Walmsley MSc MD FRCPC
Pages: 395-405
Published online: 04 Dec 2013
Abstractfor Raltegravir as antiretroviral therapy in HIV/AIDS | Full Text | References | PDF (276.9 KB)
  • 527 Views
  • 11 CrossRef citations
  • 0Altmetric
Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer
Andrea Rocca, Alberto Farolfi, Sara Bravaccini, Alessio Schirone & Dino Amadori
Pages: 407-420
Published online: 26 Dec 2013
Abstractfor Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer | Full Text | References | PDF (496.5 KB)
  • 3570 Views
  • 77 CrossRef citations
  • 0Altmetric
Alprostadil for the treatment of impotence
Vishwanath Hanchanale MBBS MS MRCS & Ian Eardley MA MChir FRCS(Urol) FEBU
Pages: 421-428
Published online: 26 Dec 2013
Abstractfor Alprostadil for the treatment of impotence | Full Text | References | PDF (389.1 KB)
  • 641 Views
  • 40 CrossRef citations
  • 0Altmetric
Selexipag for the treatment of pulmonary arterial hypertension
Nika Skoro-Sajer MD & Irene Marthe Lang MD
Pages: 429-436
Published online: 07 Jan 2014
Abstractfor Selexipag for the treatment of pulmonary arterial hypertension | Full Text | References | PDF (271.1 KB)
  • 1182 Views
  • 25 CrossRef citations
  • 0Altmetric

Key Paper Evaluation

Article
Canagliflozin – something new for type 2 diabetes, but is it safe and efficacious?
Evaluation of Inagaki N, Kondo K, Yoshinari T, et al. Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study. Diabetes Obes Metab 2013. [Epub ahead of print] and Cefalu WT, Leiter LA, Yoon KH, et al. Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomized, double-blind, phase 3 non-inferiority trial. Lancet 2013;382:941-50
Sheila A Doggrell PhD DSc & Kerry McIntyre
Pages: 437-441
Published online: 31 Dec 2013
AbstractforCanagliflozin – something new for type 2 diabetes, but is it safe and efficacious? | Full Text | References | PDF (160.9 KB)
  • 551 Views
  • 6 CrossRef citations
  • 0Altmetric

Research Article

Article
Related articles
Page: i
Published online: 16 Jan 2014
CitationforRelated articles | Full Text | PDF (81.3 KB)
  • 50 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Milvexian: evaluating the factor XIa inhibitor for the treatment of acute coronary syndrome
Udaya S. Tantry et al.
Review Article | Published online: 30 Jul 2024
Advances with janus kinase inhibitors for the treatment of myeloproliferative neoplasms: an update of the literature
Anthony M. Hunter et al.
Review Article | Published online: 27 Jul 2024
PSMA-based therapeutics for prostate cancer
Panagiotis Velissarios Stamatakos et al.
Review Article | Published online: 31 Jul 2024
Examining linaclotide for the treatment of chronic idiopathic constipation
Jeff Angelo Taclob et al.
Review Article | Published online: 26 Jul 2024
View all latest articles